Current Cancer Therapy Reviews

Editor-in-Chief

Yangchao Chen
School of Biomedical Sciences
Faculty of Medicine
The Chinese University of Hong Kong
Shatin
(Hong Kong)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Most Cited Article

Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review

Volume:16   Issue:1
Pp: 5-18
Namrata Singh, Poonam Kushwaha*, Amresh Gupta and Om Prakash
DOI: 10.2174/1573394715666181129101502

Immunoliposomes: Synthesis, Structure, and their Potential as Drug Delivery Carriers

Volume:16   Issue:4
Pp: 306-319
Divya Sandeep, Nour M. AlSawaftah and Ghaleb A. Husseini*
DOI: 10.2174/1573394716666200227095521

The Important Role of Oncolytic Viruses in Common Cancer Treatments

Volume:16   Issue:4
Pp: 292-305
Amir Mohamadi, Gilles Pagès and Mohammad S. Hashemzadeh*
DOI: 10.2174/1573394716666200211120906

Development, Characterization and Anticancer Evaluation of Silver Nanoparticles from Dalbergia sissoo Leaf Extracts open access plus

Volume:16   Issue:2
Pp: 145-151
Aakash Deep*, Mitali Verma, Rakesh K. Marwaha, Arun K. Sharma and Beena Kumari
DOI: 10.2174/1573394715666190820150651

Solanum nigrum Anticancer Effect Through Epigenetic Modulations in Breast Cancer Cell Lines

Volume:16   Issue:2
Pp: 121-126
Atefeh Shirkavand, Zahra N. Boroujeni and Seyed A. Aleyasin*
DOI: 10.2174/1573394715666190101114541

Virtual Screening of Novel Hybrid Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Exploring Multiple Targeted Cancer Therapy by an In Silico Approach open access plus

Volume:16   Issue:1
Pp: 70-77
Ashish P. Shah* and Chhagan N. Patel
DOI: 10.2174/1573394715666190618114748

Anti-carcinogenic Effect of Cathepsin K Inhibitor, Odanacatib with a Low Dose of Cisplatin Against Human Breast Carcinoma MCF-7 and MDA-MB231 Cells

Volume:17   Issue:2
Pp: 159-169
Yaongamphi Vashum, Amuthavalli Kottaiswamy, Tholcopiyan Loganathan, Fathima B. Sheriff and Shila Samuel*
DOI: 10.2174/1573394716666201222101925

Molecular Biomarkers for Lung Adenocarcinoma: A Short Review

Volume:17   Issue:2
Pp: 97-106
Srikumar Chakravarthi* and Barani Karikalan
DOI: 10.2174/1573394716666200724164654

Combination Therapy of Cisplatin and other Agents for Osteosarcoma: A Review

Volume:17   Issue:2
Pp: 137-147
Mohamad Z. Kasiram, Hermizi Hapidin*, Hasmah Abdullah, Azlina Ahmad and Sarina Sulong
DOI: 10.2174/1573394716999201016160946

Ewing Sarcoma Family Tumors: Past, Present and Future Prospects

Volume:17   Issue:2
Pp: 107-136
Adil Abbas* and Mohammed N.S. Alaa
DOI: 10.2174/1573394716999201125204643

Glioblastoma Multiforme and its Cell Interruption

Volume:17   Issue:2
Pp: 89-92
Sankha Bhattacharya*
DOI: 10.2174/1573394716999201007125709

Current and Future Scenario of Immunotherapy for the Treatment of Hepatocellular Carcinoma

Volume:17   Issue:2
Pp: 148-158
Shvetank Bhatt*, Jovita Kanoujia, Arghya K. Dhar, Rakesh K. Singh and Jayaraman Rajangam
DOI: 10.2174/1573394716999200818103724

Preface

Volume:17   Issue:1
Pp: 1-1
Yangchao Chen
DOI: 10.2174/157339471701210405113023